Clear Creek Bio doses first patient in phase 2 outpatient study of Brequinar to treat Covid-19

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 23, 2020 at 10:32 AM.

  1. #1 cafead, Nov 23, 2020 at 10:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,925
    Likes Received:
    3
    via Clear Creek Bio, Inc. announced today that the company has dosed the first patient in the CRISIS2 study, a Phase 2 clinical study evaluating brequinar for the treatment of Covid-19.

    article source
     
    Quote

Reply to Thread